Concepedia

Roman Cailleteau

RC

3

Publications

185

Citations

3

H-Index

2022

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Velocity Clinical Research (United States)

Royal Surrey NHS Foundation Trust

University of Surrey

Roman Cailleteau is an author at Novo Nordisk (Denmark).

Publications per year

2022–2023

3

Publications

3

Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial

David Russell‐Jones, Tetsuya Babazono, Roman Cailleteau et al. · The Lancet · 2023 · 96 citations · Full text

Rationale and design of the phase 3a development programme ( <scp>ONWARDS</scp> 1–6 trials) investigating once‐weekly insulin icodec in diabetes

Athena Philis‐Tsimikas, Harpreet S. Bajaj, Kamilla Begtrup et al. · Diabetes Obesity and Metabolism · 2022 · 70 citations · Full text

Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

Thomas R. Pieber, Kristine Niss Arfelt, Roman Cailleteau et al. · Diabetologia · 2023 · 19 citations · Full text

Rows per page

1–3 of 3